CARBATOL 200mg price in UAE

Overview

Welcome to Dwaey, specifically on CARBATOL 200mg Tablets page.
This medicine contains an important and useful components, as it consists of Carbamazepine.
CARBATOL 200mg is available in the market in concentration 200mg/Tablet and in the form of Tablets.

DAR AL DAWA DEVELOPMENT & INVESTMENT CO. LTD. is the producer of CARBATOL 200mg and it is imported from JORDAN, The most popular alternatives of CARBATOL 200mg are listed downward .

Mode Of Action

Carbamazepine reduces polysynaptic responses and blocks post-tetanic potentiation. It is effective in partial and generalised convulsions as well as in mixed types but not in petit mal seizures. It reduces or abolishes pain in trigeminal and glossopharyngeal neuralgia.

Indication

Epilepsy
Schizophrenia
Bipolar disorder
Trigeminal neuralgia

Precaution

Lactation; CV disease, hepatic or renal disorders, history of blood disorders or haematological reactions to other drugs; glaucoma; skin disorders; elderly, patients on MAO inhibitors; abrupt withdrawal of treatment. Lactation: Enters breast milk; not recommended (AAP states compatible with nursing; however, adverse reactions in breastfeeding infant are possible; take into account the importance of the drug to the mother before deciding to discontinue breastfeeding or the drug)

Side Effects

>10% Ataxia (15%)
Dizziness (44%)
Drowsiness (32%)
Nausea (29%)
Vomiting (18%) 1-10% Dry mouth (8%) Rare MI
Stevens-Johnson syndrome Hepatic failure
Punctate cortical lens opacities
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) Frequency Not Defined Hemopoietic system: Aplastic anemia
agranulocytosis
pancytopenia
bone marrow depression
thrombocytopenia
leukopenia
leukocytosis
eosinophilia
anemia
acute intermittent porphyria
variegate porphyria
porphyria cutanea tarda Skin: Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) (see Black Box Warnings)
pruritic and erythematous rashes
urticaria
photosensitivity reactions
alterations in skin pigmentation
exfoliative dermatitis
erythema multiforme and nodosum
purpura
aggravation of disseminated lupus erythematosus
alopecia
diaphoresis
and onychomadesis Cardiovascular system: Congestive heart failure
edema
aggravation of hypertension
hypotension
syncope and collapse
aggravation of coronary artery disease
arrhythmias and AV block
thrombophlebitis
thromboembolism
and adenopathy or lymphadenopathy Liver: Abnormalities in liver function tests
cholestatic and hepatocellular jaundice
hepatitis; very rare cases of hepatic failure Pancreatic: Pancreatitis Respiratory System: Pulmonary hypersensitivity characterized by fever
dyspnea
pneumonitis
or pneumonia Genitourinary System: Urinary frequency
acute urinary retention
oliguria with elevated blood pressure
azotemia
renal failure
and impotence (rare reports of impaired male fertility and/or abnormal spermatogenesis) Laboratory: Albuminuria
glycosuria
elevated BUN
decreased plasma calcium
and microscopic deposits in the urine Nervous system: Dizziness
drowsiness
disturbances of coordination
confusion
headache
fatigue
blurred vision
visual hallucinations
transient diplopia
oculomotor disturbances
nystagmus
speech disturbances
abnormal involuntary movements
peripheral neuritis and paresthesias
depression with agitation
talkativeness
tinnitus
hyperacusis
neuroleptic malignant syndrome; isolated cases of neuroleptic malignant syndrome Digestive system: Nausea
vomiting
gastric distress and abdominal pain
diarrhea
constipation
anorexia
and dryness of the mouth and pharynx
including glossitis
and stomatitis Eyes: Scattered punctate cortical lens opacities
increased intraocular pressure as well as conjunctivitis Musculoskeletal system: Aching joints and muscles
and leg cramps Metabolism: Fever and chills; SIADH; cases of frank water intoxication
with decreased serum sodium (hyponatremia) and confusion; decreased levels of plasma calcium leading to osteoporosis Potentially Fatal: Agranulocytosis
aplastic anaemia
hepatic failure
severe exfoliative dermatitis and Stevens-Johnson syndrome.

Contra indication

Hypersensitivity; bone marrow depression; porphyria, pregnancy.

Pregnancy and lactation

Pregnancy category: D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Interaction

Increased plasma levels w/ CYP3A4 inhibitors (e.g. cimetidine). Decreased plasma levels w/ CYP3A4 inducers (e.g. cisplatin). Increased risk of neurotoxic side effects w/ lithium. May decrease the effect of hormonal contraceptives. Increased plasma levels of active metabolite carbamazepine-10, 11-epoxide w/ loxapine, quetiapine, primidone, progabide, valproic acid and valpromide. May increase cyclophosphamide levels. May reduce exposure of aripiprazole. May reduce plasma levels of tacrolimus, temsirolimus and lapatinib. May increase risk of isoniazid-induced hepatotoxicity. Risk of symptomatic hyponatraemia w/ diuretics (e.g. hydrochlorothiazide, furosemide). Potentially Fatal: May decrease serum concentrations of nefazodone and its active metabolites. Toxic reactions may develop when taken concurrently w/ MAOIs.